Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotizing Autoimmune Myositis Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Steroid Drugs
1.2.3 Immunosuppressant
1.2.4 Others
1.3 Market by Application
1.3.1 Global Necrotizing Autoimmune Myositis Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Necrotizing Autoimmune Myositis Market Perspective (2018-2034)
2.2 Necrotizing Autoimmune Myositis Growth Trends by Region
2.2.1 Global Necrotizing Autoimmune Myositis Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Necrotizing Autoimmune Myositis Historic Market Size by Region (2018-2023)
2.2.3 Necrotizing Autoimmune Myositis Forecasted Market Size by Region (2024-2034)
2.3 Necrotizing Autoimmune Myositis Market Dynamics
2.3.1 Necrotizing Autoimmune Myositis Industry Trends
2.3.2 Necrotizing Autoimmune Myositis Market Drivers
2.3.3 Necrotizing Autoimmune Myositis Market Challenges
2.3.4 Necrotizing Autoimmune Myositis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Autoimmune Myositis Players by Revenue
3.1.1 Global Top Necrotizing Autoimmune Myositis Players by Revenue (2018-2023)
3.1.2 Global Necrotizing Autoimmune Myositis Revenue Market Share by Players (2018-2023)
3.2 Global Necrotizing Autoimmune Myositis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Autoimmune Myositis Revenue
3.4 Global Necrotizing Autoimmune Myositis Market Concentration Ratio
3.4.1 Global Necrotizing Autoimmune Myositis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Autoimmune Myositis Revenue in 2024
3.5 Necrotizing Autoimmune Myositis Key Players Head office and Area Served
3.6 Key Players Necrotizing Autoimmune Myositis Product Solution and Service
3.7 Date of Enter into Necrotizing Autoimmune Myositis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Necrotizing Autoimmune Myositis Breakdown Data by Type
4.1 Global Necrotizing Autoimmune Myositis Historic Market Size by Type (2018-2023)
4.2 Global Necrotizing Autoimmune Myositis Forecasted Market Size by Type (2024-2034)
5 Necrotizing Autoimmune Myositis Breakdown Data by Application
5.1 Global Necrotizing Autoimmune Myositis Historic Market Size by Application (2018-2023)
5.2 Global Necrotizing Autoimmune Myositis Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Necrotizing Autoimmune Myositis Market Size (2018-2034)
6.2 North America Necrotizing Autoimmune Myositis Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Necrotizing Autoimmune Myositis Market Size by Country (2018-2023)
6.4 North America Necrotizing Autoimmune Myositis Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Necrotizing Autoimmune Myositis Market Size (2018-2034)
7.2 Europe Necrotizing Autoimmune Myositis Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Necrotizing Autoimmune Myositis Market Size by Country (2018-2023)
7.4 Europe Necrotizing Autoimmune Myositis Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Autoimmune Myositis Market Size (2018-2034)
8.2 Asia-Pacific Necrotizing Autoimmune Myositis Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Necrotizing Autoimmune Myositis Market Size by Region (2018-2023)
8.4 Asia-Pacific Necrotizing Autoimmune Myositis Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Necrotizing Autoimmune Myositis Market Size (2018-2034)
9.2 Latin America Necrotizing Autoimmune Myositis Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Necrotizing Autoimmune Myositis Market Size by Country (2018-2023)
9.4 Latin America Necrotizing Autoimmune Myositis Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Autoimmune Myositis Market Size (2018-2034)
10.2 Middle East & Africa Necrotizing Autoimmune Myositis Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Country (2018-2023)
10.4 Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Detail
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Necrotizing Autoimmune Myositis Introduction
11.1.4 GlaxoSmithKline plc Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Dr. Reddy's Laboratories
11.2.1 Dr. Reddy's Laboratories Company Detail
11.2.2 Dr. Reddy's Laboratories Business Overview
11.2.3 Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Introduction
11.2.4 Dr. Reddy's Laboratories Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.2.5 Dr. Reddy's Laboratories Recent Development
11.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
11.3.1 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Company Detail
11.3.2 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Business Overview
11.3.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Introduction
11.3.4 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.3.5 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Recent Development
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Company Detail
11.4.2 Hetero Drugs Limited Business Overview
11.4.3 Hetero Drugs Limited Necrotizing Autoimmune Myositis Introduction
11.4.4 Hetero Drugs Limited Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.4.5 Hetero Drugs Limited Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Detail
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. Necrotizing Autoimmune Myositis Introduction
11.5.4 AbbVie Inc. Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.5.5 AbbVie Inc. Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Detail
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Necrotizing Autoimmune Myositis Introduction
11.7.4 Novartis AG Revenue in Necrotizing Autoimmune Myositis Business (2018-2023)
11.7.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Necrotizing Autoimmune Myositis Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Steroid Drugs
Table 3. Key Players of Immunosuppressant
Table 4. Key Players of Others
Table 5. Global Necrotizing Autoimmune Myositis Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Necrotizing Autoimmune Myositis Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Necrotizing Autoimmune Myositis Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Necrotizing Autoimmune Myositis Market Share by Region (2018-2023)
Table 9. Global Necrotizing Autoimmune Myositis Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Necrotizing Autoimmune Myositis Market Share by Region (2024-2034)
Table 11. Necrotizing Autoimmune Myositis Market Trends
Table 12. Necrotizing Autoimmune Myositis Market Drivers
Table 13. Necrotizing Autoimmune Myositis Market Challenges
Table 14. Necrotizing Autoimmune Myositis Market Restraints
Table 15. Global Necrotizing Autoimmune Myositis Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Necrotizing Autoimmune Myositis Market Share by Players (2018-2023)
Table 17. Global Top Necrotizing Autoimmune Myositis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Autoimmune Myositis as of 2024)
Table 18. Ranking of Global Top Necrotizing Autoimmune Myositis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Necrotizing Autoimmune Myositis Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Necrotizing Autoimmune Myositis Product Solution and Service
Table 22. Date of Enter into Necrotizing Autoimmune Myositis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Necrotizing Autoimmune Myositis Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Necrotizing Autoimmune Myositis Revenue Market Share by Type (2018-2023)
Table 26. Global Necrotizing Autoimmune Myositis Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Necrotizing Autoimmune Myositis Revenue Market Share by Type (2024-2034)
Table 28. Global Necrotizing Autoimmune Myositis Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Necrotizing Autoimmune Myositis Revenue Market Share by Application (2018-2023)
Table 30. Global Necrotizing Autoimmune Myositis Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Necrotizing Autoimmune Myositis Revenue Market Share by Application (2024-2034)
Table 32. North America Necrotizing Autoimmune Myositis Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Necrotizing Autoimmune Myositis Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Necrotizing Autoimmune Myositis Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Necrotizing Autoimmune Myositis Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Necrotizing Autoimmune Myositis Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Necrotizing Autoimmune Myositis Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Necrotizing Autoimmune Myositis Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Necrotizing Autoimmune Myositis Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Necrotizing Autoimmune Myositis Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Necrotizing Autoimmune Myositis Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Necrotizing Autoimmune Myositis Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Necrotizing Autoimmune Myositis Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Necrotizing Autoimmune Myositis Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Necrotizing Autoimmune Myositis Market Size by Country (2024-2034) & (US$ Million)
Table 47. GlaxoSmithKline plc Company Detail
Table 48. GlaxoSmithKline plc Business Overview
Table 49. GlaxoSmithKline plc Necrotizing Autoimmune Myositis Product
Table 50. GlaxoSmithKline plc Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline plc Recent Development
Table 52. Dr. Reddy's Laboratories Company Detail
Table 53. Dr. Reddy's Laboratories Business Overview
Table 54. Dr. Reddy's Laboratories Necrotizing Autoimmune Myositis Product
Table 55. Dr. Reddy's Laboratories Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 56. Dr. Reddy's Laboratories Recent Development
Table 57. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Company Detail
Table 58. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Business Overview
Table 59. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Necrotizing Autoimmune Myositis Product
Table 60. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 61. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Recent Development
Table 62. Hetero Drugs Limited Company Detail
Table 63. Hetero Drugs Limited Business Overview
Table 64. Hetero Drugs Limited Necrotizing Autoimmune Myositis Product
Table 65. Hetero Drugs Limited Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 66. Hetero Drugs Limited Recent Development
Table 67. AbbVie Inc. Company Detail
Table 68. AbbVie Inc. Business Overview
Table 69. AbbVie Inc. Necrotizing Autoimmune Myositis Product
Table 70. AbbVie Inc. Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 71. AbbVie Inc. Recent Development
Table 72. Teva Pharmaceutical Industries Company Detail
Table 73. Teva Pharmaceutical Industries Business Overview
Table 74. Teva Pharmaceutical Industries Necrotizing Autoimmune Myositis Product
Table 75. Teva Pharmaceutical Industries Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 76. Teva Pharmaceutical Industries Recent Development
Table 77. Novartis AG Company Detail
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Necrotizing Autoimmune Myositis Product
Table 80. Novartis AG Revenue in Necrotizing Autoimmune Myositis Business (2018-2023) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Autoimmune Myositis Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Necrotizing Autoimmune Myositis Market Share by Type: 2024 VS 2034
Figure 3. Steroid Drugs Features
Figure 4. Immunosuppressant Features
Figure 5. Others Features
Figure 6. Global Necrotizing Autoimmune Myositis Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Necrotizing Autoimmune Myositis Market Share by Application: 2024 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Necrotizing Autoimmune Myositis Report Years Considered
Figure 12. Global Necrotizing Autoimmune Myositis Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Necrotizing Autoimmune Myositis Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Necrotizing Autoimmune Myositis Market Share by Region: 2024 VS 2034
Figure 15. Global Necrotizing Autoimmune Myositis Market Share by Players in 2024
Figure 16. Global Top Necrotizing Autoimmune Myositis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Autoimmune Myositis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Necrotizing Autoimmune Myositis Revenue in 2024
Figure 18. North America Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Necrotizing Autoimmune Myositis Market Share by Country (2018-2034)
Figure 20. United States Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Necrotizing Autoimmune Myositis Market Share by Country (2018-2034)
Figure 24. Germany Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Necrotizing Autoimmune Myositis Market Share by Region (2018-2034)
Figure 32. China Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Necrotizing Autoimmune Myositis Market Share by Country (2018-2034)
Figure 40. Mexico Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Necrotizing Autoimmune Myositis Market Share by Country (2018-2034)
Figure 44. Turkey Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Necrotizing Autoimmune Myositis Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. GlaxoSmithKline plc Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 47. Dr. Reddy's Laboratories Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 48. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 49. Hetero Drugs Limited Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 50. AbbVie Inc. Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 52. Novartis AG Revenue Growth Rate in Necrotizing Autoimmune Myositis Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed